Updates are available Correction dated 2017-11-07
Click to view Correction: https://doi.org/10.1007/s11657-017-0394-4
Updates are available Correction dated 2023-02-22
Click to view Correction: https://doi.org/10.1007/s11657-023-01223-z
-
Authors
Gourlay, Margaret L.
Ritter, Victor S.
Fine, Jason P.
Overman, Robert A.
Schousboe, John T.
Cawthon, Peggy M.
Orwoll, Eric S.
Nguyen, Tuan V.
Lane, Nancy E.
Cummings, Steven R.
Kado, Deborah M.
Lapidus, Jodi A.
Diem, Susan J.
Ensrud, Kristine E.
,
- License Information
-
More Information
Article History
Received: 20 July 2017
Accepted: 10 October 2017
First Online: 20 October 2017
Change Date: 7 November 2017
Change Type: Correction
Change Details: Owing to an oversight by the authors, the acknowledgments were incomplete.
Change Date: 22 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11657-023-01223-z
Compliance with ethical standards
:
: The content is solely the responsibility of the authors and does not necessarily reflect the official views of the funding agencies. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication. Dr. Cawthon reports research grants from GlaxoSmithKline. Dr. Orwoll has received research and consulting support from Merck, Eli Lilly, and Amgen. Dr. Lane has received research and or consulting support from Merck, Amgen, and Regeneron. Dr. Kado has received consultant support from Kalytera Therapeutics, Takeda Pharmaceuticals, and Amgen. No other financial disclosures were reported by the authors of this paper.
